These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 8823305

  • 21. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody.
    Luo JC, Toyoda M, Shibuya M.
    Cancer Res; 1998 Jun 15; 58(12):2594-600. PubMed ID: 9635584
    [Abstract] [Full Text] [Related]

  • 22. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
    Joseph IB, Isaacs JT.
    Cancer Res; 1997 Mar 15; 57(6):1054-7. PubMed ID: 9067270
    [Abstract] [Full Text] [Related]

  • 23. Studies of glomerular permeability factor (GPF) in focal segmental glomerular sclerosis and the relationship between GPF and vascular permeability factor (VPF).
    Kondo S, Yoshizawa N, Kusumi Y, Takeuchi A, Torikata C.
    Clin Nephrol; 1999 Nov 15; 52(5):278-84. PubMed ID: 10584990
    [Abstract] [Full Text] [Related]

  • 24. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F, Markham PD, Gendelman R, Watanabe Y, Kao V, Kowalski K, Sonnabend JA, Pintus A, Gallo RC, Ensoli B.
    Am J Pathol; 1998 Jun 15; 152(6):1433-43. PubMed ID: 9626048
    [Abstract] [Full Text] [Related]

  • 25. Increase in brain tumor permeability in glioma-bearing rats with nitric oxide donors.
    Yin D, Wang X, Konda BM, Ong JM, Hu J, Sacapano MR, Ko MK, Espinoza AJ, Irvin DK, Shu Y, Black KL.
    Clin Cancer Res; 2008 Jun 15; 14(12):4002-9. PubMed ID: 18559623
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Dexamethasone inhibits glioma-induced formation of capillary like structures in vitro and angiogenesis in vivo.
    Wolff JE, Mölenkamp G, Hotfilder M, Laterra J.
    Klin Padiatr; 1997 Jun 15; 209(4):275-7. PubMed ID: 9293462
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Capillary permeability factor produced by C 6 glioma cells: role in peritumoral brain edema and possible mechanism of glucocorticoid action].
    Ohnishi T, Hayakawa T, Arita N, Mogami H, Ushio Y, Shapiro WR.
    No To Shinkei; 1989 Nov 15; 41(11):1141-7. PubMed ID: 2620014
    [Abstract] [Full Text] [Related]

  • 31. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells.
    Detmar M, Yeo KT, Nagy JA, Van de Water L, Brown LF, Berse B, Elicker BM, Ledbetter S, Dvorak HF.
    J Invest Dermatol; 1995 Jul 15; 105(1):44-50. PubMed ID: 7615975
    [Abstract] [Full Text] [Related]

  • 32. Inhibition by tranilast of vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF)-induced increase in vascular permeability in rats.
    Isaji M, Miyata H, Ajisawa Y, Yoshimura N.
    Life Sci; 1998 Jul 15; 63(4):PL71-4. PubMed ID: 9698042
    [Abstract] [Full Text] [Related]

  • 33. Vascular differentiation and glucose transporter expression in rat gliomas: effects of steroids.
    Guerin C, Wolff JE, Laterra J, Drewes LR, Brem H, Goldstein GW.
    Ann Neurol; 1992 May 15; 31(5):481-7. PubMed ID: 1596083
    [Abstract] [Full Text] [Related]

  • 34. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody.
    Yuan F, Chen Y, Dellian M, Safabakhsh N, Ferrara N, Jain RK.
    Proc Natl Acad Sci U S A; 1996 Dec 10; 93(25):14765-70. PubMed ID: 8962129
    [Abstract] [Full Text] [Related]

  • 35. Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: implications for tumor angiogenesis.
    Kevil CG, De Benedetti A, Payne DK, Coe LL, Laroux FS, Alexander JS.
    Int J Cancer; 1996 Mar 15; 65(6):785-90. PubMed ID: 8631593
    [Abstract] [Full Text] [Related]

  • 36. Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor.
    Senger DR, Connolly DT, Van de Water L, Feder J, Dvorak HF.
    Cancer Res; 1990 Mar 15; 50(6):1774-8. PubMed ID: 2155059
    [Abstract] [Full Text] [Related]

  • 37. Characterization of a protein product of human malignant glial tumors that induces microvascular permeability.
    Criscuolo GR, Merrill MJ, Oldfield EH.
    Adv Neurol; 1990 Mar 15; 52():469-74. PubMed ID: 2396540
    [No Abstract] [Full Text] [Related]

  • 38. Neoplastic and pharmacological influence on the permeability of an in vitro blood-brain barrier.
    Grabb PA, Gilbert MR.
    J Neurosurg; 1995 Jun 15; 82(6):1053-8. PubMed ID: 7760177
    [Abstract] [Full Text] [Related]

  • 39. Scatter factor/hepatocyte growth factor gene transfer increases rat blood-glioma barrier permeability.
    Book AA, Ranganathan S, Abounader R, Rosen E, Laterra J.
    Brain Res; 1999 Jul 03; 833(2):173-80. PubMed ID: 10375692
    [Abstract] [Full Text] [Related]

  • 40. Effects of vascular permeability factor on the permeability of cultured endothelial cells from brain capillaries.
    Zhao L, Zhang MM, Ng KY.
    J Cardiovasc Pharmacol; 1998 Jul 03; 32(1):1-4. PubMed ID: 9676713
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.